NEW YORK (
CHANGE IN RATINGS
was upgraded to Buy at TheStreet Ratings.
was upgraded at UBS to Buy from Neutral. $11 price target. Negative catalysts behind us, moving past the debt/dividend overhang, UBS said.
(DHI - Get Report)
was upgraded at Guggenheim to Buy from Neutral. Home pricing is firming on higher demand, Guggenheim said. $27 price target.
was upgraded at JP Morgan to Overweight from Neutral. $22 price target. Risk/reward too compelling to ignore, JP Morgan said.
was upgraded at UBS to Neutral from Sell. $21 price target. Progress on lease-up portfolio, UBS said.
was upgraded at Sterne Agee to Buy from Neutral. $18 price target. Stronger domestic outlook and acquisition optionality, Sterne Agee said.
(LEN - Get Report)
was upgraded at Guggenheim from Neutral to Buy. $39 price target. Low supply is helping new home pricing, Guggenheim said.
was upgraded at JP Morgan to Overweight from Neutral. $16 price target. Increased confidence in the growth outlook and risk profile, JP Morgan said.
was upgraded at Robert Baird from Neutral to Outperform. Valuation call, as the sector should benefit from a defensive sector rotation, Baird said.
(NOK - Get Report)
was downgraded at Societe Generale from Hold to Sell. Business is likely to deteriorate further, Societe Generale said.
was downgraded at UBS to Neutral from Buy. $49 price target. Growth is peaking, as is sentiment, UBS said.
was downgraded at Wedbush from Outperform to Neutral. $29 price target. Pricing will likely become more competitive, in order to maintain volume growth, Wedbush said.
(SPLK - Get Report)
was initiated with a rated new Neutral rating at UBS. $33 price target. Valuation attracts attention and high expectations, UBS said.
Splunk was initiated with an Equal-Weight rating at Morgan Stanley. Valuation call, Morgan Stanley said.
Splunk was initiated with an Outperform rating at Credit Suisse. $40 price target. Company has a disruptive technology and massive market opportunity, Credit Suisse said.
was downgraded at Goldman Sachs from Neutral to Sell. Company will likely generate less free cash flow in the coming quarters, Goldman said. $14 price target.